Erythropoietin Drug
The global Erythropoietin Drug market was valued at 8277.44 Million USD in 2021 and will grow with a CAGR of 5.86% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
By Market Verdors
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
By Types
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
By Applications
Anemia
Kidney Disorders
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Erythropoietin Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Erythropoietin Drug Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Epoetin-alfa
1.4.3 Darbepoetin-alfa
1.4.4 Epoetin-beta
1.5 Market by Application
1.5.1 Global Erythropoietin Drug Market Share by Application: 2022-2027
1.5.2 Anemia
1.5.3 Kidney Disorders
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Erythropoietin Drug Market
1.8.1 Global Erythropoietin Drug Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Erythropoietin Drug Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Erythropoietin Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Erythropoietin Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Erythropoietin Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Erythropoietin Drug Sales Volume Market Share by Region (2016-2021)
3.2 Global Erythropoietin Drug Sales Revenue Market Share by Region (2016-2021)
3.3 North America Erythropoietin Drug Sales Volume
3.3.1 North America Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.3.2 North America Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Erythropoietin Drug Sales Volume
3.4.1 East Asia Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Erythropoietin Drug Sales Volume (2016-2021)
3.5.1 Europe Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Erythropoietin Drug Sales Volume (2016-2021)
3.6.1 South Asia Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Erythropoietin Drug Sales Volume (2016-2021)
3.7.1 Southeast Asia Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Erythropoietin Drug Sales Volume (2016-2021)
3.8.1 Middle East Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Erythropoietin Drug Sales Volume (2016-2021)
3.9.1 Africa Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Erythropoietin Drug Sales Volume (2016-2021)
3.10.1 Oceania Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Erythropoietin Drug Sales Volume (2016-2021)
3.11.1 South America Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.11.2 South America Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Erythropoietin Drug Sales Volume (2016-2021)
3.12.1 Rest of the World Erythropoietin Drug Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Erythropoietin Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Erythropoietin Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Erythropoietin Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Erythropoietin Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Erythropoietin Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Erythropoietin Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Erythropoietin Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Erythropoietin Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Erythropoietin Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Erythropoietin Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Erythropoietin Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Erythropoietin Drug Sales Volume Market Share by Type (2016-2021)
14.2 Global Erythropoietin Drug Sales Revenue Market Share by Type (2016-2021)
14.3 Global Erythropoietin Drug Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Erythropoietin Drug Consumption Volume by Application (2016-2021)
15.2 Global Erythropoietin Drug Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Erythropoietin Drug Business
16.1 Amgen
16.1.1 Amgen Company Profile
16.1.2 Amgen Erythropoietin Drug Product Specification
16.1.3 Amgen Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Johnson & Johnson
16.2.1 Johnson & Johnson Company Profile
16.2.2 Johnson & Johnson Erythropoietin Drug Product Specification
16.2.3 Johnson & Johnson Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Roche
16.3.1 Roche Company Profile
16.3.2 Roche Erythropoietin Drug Product Specification
16.3.3 Roche Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Galenica
16.4.1 Galenica Company Profile
16.4.2 Galenica Erythropoietin Drug Product Specification
16.4.3 Galenica Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Emcure
16.5.1 Emcure Company Profile
16.5.2 Emcure Erythropoietin Drug Product Specification
16.5.3 Emcure Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Kyowa Hakko Kirin
16.6.1 Kyowa Hakko Kirin Company Profile
16.6.2 Kyowa Hakko Kirin Erythropoietin Drug Product Specification
16.6.3 Kyowa Hakko Kirin Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 3SBio
16.7.1 3SBio Company Profile
16.7.2 3SBio Erythropoietin Drug Product Specification
16.7.3 3SBio Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Biocon
16.8.1 Biocon Company Profile
16.8.2 Biocon Erythropoietin Drug Product Specification
16.8.3 Biocon Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 LG Life Sciences
16.9.1 LG Life Sciences Company Profile
16.9.2 LG Life Sciences Erythropoietin Drug Product Specification
16.9.3 LG Life Sciences Erythropoietin Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Erythropoietin Drug Manufacturing Cost Analysis
17.1 Erythropoietin Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Erythropoietin Drug
17.4 Erythropoietin Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Erythropoietin Drug Distributors List
18.3 Erythropoietin Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Erythropoietin Drug (2022-2027)
20.2 Global Forecasted Revenue of Erythropoietin Drug (2022-2027)
20.3 Global Forecasted Price of Erythropoietin Drug (2016-2027)
20.4 Global Forecasted Production of Erythropoietin Drug by Region (2022-2027)
20.4.1 North America Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.3 Europe Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.7 Africa Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.9 South America Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Erythropoietin Drug Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Erythropoietin Drug by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Erythropoietin Drug by Country
21.2 East Asia Market Forecasted Consumption of Erythropoietin Drug by Country
21.3 Europe Market Forecasted Consumption of Erythropoietin Drug by Countriy
21.4 South Asia Forecasted Consumption of Erythropoietin Drug by Country
21.5 Southeast Asia Forecasted Consumption of Erythropoietin Drug by Country
21.6 Middle East Forecasted Consumption of Erythropoietin Drug by Country
21.7 Africa Forecasted Consumption of Erythropoietin Drug by Country
21.8 Oceania Forecasted Consumption of Erythropoietin Drug by Country
21.9 South America Forecasted Consumption of Erythropoietin Drug by Country
21.10 Rest of the world Forecasted Consumption of Erythropoietin Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices